Angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor antagonists have become an important tool for the treatment of hypertension and its cardiovascular complications. Inhibition ...

Please provide your email address to receive an email when new articles are posted on . RAS blockers had similar mortality benefit by race in patients with HFrEF. RAS blockers improved HF ...

Multiple recent studies highlight the renin-angiotensin-aldosterone system (RAAS) as a critical factor in COVID-19 severity, with ACE2 dysregulation influencing inflammation, vascular damage, and ...

In a recent study posted to the medRxiv* preprint server, researchers conducted an umbrella review and meta-analysis of the renin-angiotensin-aldosterone system (RAAS) inhibitors' impact on ...

Please provide your email address to receive an email when new articles are posted on . Compared with ACE inhibitors, beta-blockers, calcium channel blockers, diuretic and no treatment at all, ...

Cost-effectiveness of NALIRIFOX compared to other first-line treatments for metastatic pancreatic cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This ...

Empirical and theoretical studies can be distinguished among the areas of investigation of the renin-angiotensin-aldosterone system (RAAS) and its relationship with the development of cardiovascular ...

Scientists have discovered a new generation of angiotensin receptor blockers that may be used to treat coronavirus disease 2019 (COVID-19). In silico docking and molecular dynamics studies have shown ...

Inhibitor of differentiation-1 (Id1) characterization in poor prognosis (PP) hormone-refractory (HR) metastatic prostate cancer (CaP) primary tumors and matched metastases (MTS) using a new monoclonal ...

Your kidneys aren’t just filters—they’re also hormone hubs that help control blood pressure, calcium, and bone health. Hormones like parathyroid hormone, calcitonin, and those in the renin–angiotensin ...